Study of the pharmacokinetics of non-immunogenic staphylokinase in patients with acute myocardial infarction and acute ischemic stroke

The aim. To investigate the pharmacokinetic parameters of non-immunogenic staphylokinase (Fortelyzin®, SuperGene LLC, Russia) in patients with acute myocardial infarction with ST-segment elevation (STEMI) on the electrocardiogram and in patients with ischemic stroke.Materials and methods. The clinic...

Descrición completa

Detalles Bibliográficos

Principais autores:	S. V. Ivanov, I. P. Beletsky, M. V. Zakharova, E. A. Ponomarev, Zh. Yu. Chefranova, S. L. Konstantinov, G. I. Stryabkova, Yu. A. Lykov, U. A. Yelemanov, S. E. Chuprina, S. S. Markin
Formato:	Artigo
Idioma:	Russo
Publicado:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2025-09-01
Series:	Фармация и фармакология (Пятигорск)
Assuntos:	неиммуногенная стафилокиназа фармакокинетика тромболизис инфаркт миокарда ишемический инсульт
Acceso en liña:	https://www.pharmpharm.ru/jour/article/view/1732
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!